ARK Israel Innovative Technology ETF (IZRL)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
ARK Israel Innovative Technology ETF (IZRL) trades at $30.69 with AI Score 47/100 (Grade C). The ARK Israel Innovative Technology ETF (IZRL) is an exchange-traded fund designed to track the performance of the ARK Israeli Innovation Index. Market cap: $153.13M, Sector: Financial services.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for IZRL: IZRL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IZRL against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
IZRL: the 1 perspectives are evenly split.
How is this calculated? →ARK Israel Innovative Technology ETF (IZRL) Financial Services Profile
The ARK Israel Innovative Technology ETF (IZRL) provides targeted exposure to publicly traded Israeli companies driving transformative innovation across high-growth sectors like genomics, healthcare, biotechnology, industrial production, manufacturing, the Internet, and information technology. It seeks to replicate the performance of the ARK Israeli Innovation Index, offering a focused investment vehicle.
What Is the Investment Thesis for IZRL?
The ARK Israel Innovative Technology ETF (IZRL) offers investors a focused vehicle to gain exposure to Israel's innovative technology sector, a region known for its robust entrepreneurial spirit and significant R&D contributions. With a market capitalization of $153.13M and a Beta of 0.89, IZRL provides a targeted investment in companies driving transformative innovation across key sectors like healthcare, software, and communications, as defined by the ARK Israeli Innovation Index. The fund's strength lies in its concentrated approach to a country celebrated for technological prowess, potentially benefiting from ongoing advancements and global demand for innovative solutions. However, its concentrated geographic focus presents an ongoing risk, making it vulnerable to regional economic or political instability. Investors should closely monitor the performance of the Israeli tech sector and geopolitical developments, as these factors directly influence the fund's underlying assets and overall performance. The ETF does not pay a dividend, emphasizing its growth-oriented mandate.
Based on FMP financials and quantitative analysis
IZRL Key Highlights
- Market Capitalization of $153.13M, indicating a specialized, niche investment vehicle within the ETF landscape.
- Beta of 0.89, suggesting lower volatility compared to the broader market, potentially offering relative stability.
- No dividend yield, aligning with its growth-oriented strategy focused on capital appreciation from innovative companies.
- Provides targeted exposure to Israeli companies driving transformative innovation across high-growth sectors.
- Replicates the performance of the ARK Israeli Innovation Index, offering a transparent and rules-based investment approach.
Who Are IZRL's Competitors?
IZRL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NXDT NexPoint Diversified Real Estate Trust | $5.36 | +1.32% | $277.24M | 73 |
| GENB Generate Biomedicines, Inc. | $17.41 | +5.52% | $2.23B | 72 |
| SII Sprott Inc. | $114.98 | +2.00% | $2.96B | 71 |
| IDDTF AB Industrivärden (publ) | $34.25 | +0.00% | $14.79B | 70 |
| JBARF Julius Bär Gruppe AG | $90.48 | +3.35% | $18.55B | 62 |
| ARES Ares Management Corporation | $116.90 | +2.88% | $38.39B | 62 |
| MERFX The Merger Fund - Class A | $17.50 | -0.06% | $2.50B | 62 |
| MPA BlackRock MuniYield Pennsylvania Quality Fund | $11.39 | +0.00% | $147.50M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IZRL's Key Strengths?
- Targeted exposure to Israel's highly innovative technology sector, known for its entrepreneurial ecosystem.
- Diversification across multiple high-growth sectors within Israel, including genomics, healthcare, and IT.
- Rules-based index replication strategy offers transparency and consistency.
- Managed by ARK Invest, a firm recognized for its expertise in disruptive innovation.
What Are IZRL's Weaknesses?
- Concentrated geographic focus makes the fund vulnerable to regional economic or political instability.
- Relatively small market capitalization ($0.15B) may limit liquidity compared to larger ETFs.
- No dividend yield, which may not appeal to income-focused investors.
- Performance is directly tied to the ARK Israeli Innovation Index, with no active management overlay to mitigate index-specific risks.
What Could Drive IZRL Stock Higher?
- Continued strong performance and innovation from Israeli technology companies, driving the underlying index's growth.
- Increased global investor allocation to thematic ETFs focused on innovation and specific geographic regions.
- Potential for new, highly innovative Israeli companies to conduct IPOs and become eligible for inclusion in the ARK Israeli Innovation Index.
- Favorable geopolitical developments in the Middle East region, enhancing investor confidence in Israeli markets.
- Significant technological breakthroughs in genomics, AI, or cybersecurity by Israeli firms, attracting global attention and investment.
What Are the Key Risks for IZRL?
- Geopolitical instability and conflict in the Middle East region, which could significantly impact Israeli economic conditions and market sentiment.
- Economic downturns or recessions within Israel, directly affecting the profitability and growth prospects of the underlying companies.
- Underperformance of the ARK Israeli Innovation Index due to sector-specific headwinds or a decline in investor interest in Israeli technology.
- Currency fluctuations between the US dollar and the Israeli New Shekel, which could impact the fund's returns for US investors.
- Market concentration risk due to the fund's exclusive focus on a single country and a specific set of high-growth technology sectors.
What Are the Growth Opportunities for IZRL?
- Growth of Israeli Tech Sector: Israel, often dubbed the 'Startup Nation,' continues to foster a dynamic environment for technological advancement. With a robust venture capital ecosystem, significant government support for R&D, and a high concentration of skilled talent, the sector is projected to expand significantly. This organic growth within the underlying Israeli innovative companies, spanning genomics, healthcare, and IT, directly contributes to the ETF's potential for capital appreciation. As more innovative companies emerge and mature, they may become eligible for inclusion in the ARK Israeli Innovation Index, enhancing the fund's asset base and attracting further investor interest in specialized geographic technology funds. This trend is expected to continue over the next 5-10 years.
- Increased Investor Interest in Thematic ETFs: There is a growing global trend among institutional and retail investors to allocate capital to thematic exchange-traded funds that offer exposure to specific megatrends or innovation themes. IZRL, with its clear focus on Israeli innovation, aligns perfectly with this trend. As investors seek diversification beyond traditional market cap-weighted indices and look for targeted growth opportunities, demand for funds like IZRL is likely to increase. This shift in investment preference, driven by a desire for specialized exposure and potential outperformance in niche sectors, provides a significant tailwind for IZRL's asset under management (AUM) growth over the medium term (3-7 years).
- Diversification Benefits for Global Portfolios: Investing in IZRL offers diversification benefits for global portfolios by providing exposure to a unique geographic and thematic segment. Israeli technology companies often have distinct risk-return profiles compared to those in larger, more mature markets. For investors seeking to reduce correlation with broader market movements or gain access to a less-explored innovation hub, IZRL presents a compelling option. This diversification appeal can attract institutional investors and wealth managers looking to optimize portfolio construction and enhance risk-adjusted returns, thereby contributing to the ETF's AUM growth as part of a broader asset allocation strategy over the long term (5-10 years).
- Innovation in Genomics and Biotechnology: The sectors of genomics and biotechnology are experiencing rapid advancements globally, driven by breakthroughs in gene editing, personalized medicine, and bioinformatics. Israel has a strong presence in these fields, with numerous companies at the forefront of research and development. IZRL's mandate to include companies in these areas positions it to capitalize on the substantial growth potential within these industries. As these technologies mature and find broader applications, the market size for related products and services is expected to expand exponentially, directly benefiting the innovative Israeli companies within IZRL's index. This growth driver is a long-term catalyst, spanning the next decade and beyond.
- Expansion of Industrial Production and IT Innovation: Beyond healthcare and biotech, IZRL also targets Israeli companies driving innovation in industrial production, manufacturing, the Internet, and information technology. These sectors are undergoing transformative changes driven by automation, artificial intelligence, cybersecurity, and cloud computing. Israel's expertise in these areas, particularly in cybersecurity and enterprise software, positions companies within the index to capture significant market share in evolving global industries. The continuous demand for advanced industrial solutions and cutting-edge IT infrastructure provides a sustained growth opportunity for the ETF's underlying holdings, contributing to its performance over the medium to long term (5-10 years).
What Opportunities Does IZRL Have?
- Continued growth and innovation within the Israeli tech sector, leading to new companies joining the index.
- Increasing global investor demand for thematic and country-specific ETFs offering unique growth stories.
- Potential for increased assets under management (AUM) as investors seek diversification benefits from non-correlated markets.
- Expansion into new innovative sub-sectors within Israel, broadening the fund's investment universe.
What Threats Does IZRL Face?
- Geopolitical instability and conflict in the Middle East region could negatively impact Israeli markets.
- Economic downturns or regulatory changes in Israel could adversely affect underlying company performance.
- Competition from other global technology ETFs or country-specific funds offering similar exposure.
- Underperformance of the ARK Israeli Innovation Index relative to broader market benchmarks.
What Are IZRL's Competitive Advantages?
- Specialized geographic and thematic focus on Israeli innovative technology companies.
- Proprietary ARK Israeli Innovation Index methodology, defining its unique investment universe.
- Association with the ARK Invest brand, known for its focus on disruptive innovation.
- Diversification benefits within a single fund, offering a basket of innovative Israeli firms.
What Does IZRL Do?
The ARK Israel Innovative Technology ETF, identified by its ticker IZRL, is a financial product designed to mirror the financial performance of the ARK Israeli Innovation Index, before accounting for any associated fees and expenses. Established with a clear mandate, IZRL provides investors with a specialized avenue to access the dynamic Israeli technology landscape. The underlying ARK Israeli Innovation Index is meticulously constructed to monitor the stock fluctuations of Israeli companies that are publicly traded and whose core business activities are centered on driving transformative innovation. These innovative efforts span a diverse array of high-growth sectors critical to the global economy. Specifically, the fund targets companies involved in genomics, a field focused on the structure, function, evolution, and mapping of genomes; healthcare, encompassing advancements in medical technology and services; biotechnology, which applies biological processes for industrial and other purposes; industrial production, involving advanced manufacturing techniques; and the expansive domains of the Internet and information technology. Headquartered in Saint Petersburg, US, IZRL operates within the Asset Management - Global industry, offering a unique thematic and geographic investment proposition. The ETF's strategy is rooted in identifying and tracking companies that are considered to be at the forefront of technological advancement within Israel, a nation widely recognized for its entrepreneurial ecosystem and significant contributions to global innovation.
What Products and Services Does IZRL Offer?
- Replicates the performance of the ARK Israeli Innovation Index, before fees and expenses.
- Invests in publicly traded Israeli companies focused on transformative innovation.
- Provides exposure to high-growth sectors including genomics, healthcare, and biotechnology.
- Includes companies involved in industrial production, manufacturing, the Internet, and information technology.
- Offers a single-country, thematic investment vehicle for accessing Israeli technological advancements.
- Operates as an exchange-traded fund (ETF), providing liquidity and diversification within its mandate.
How Does IZRL Make Money?
- Generates revenue primarily through management fees charged to investors for managing the fund.
- Aims to achieve capital appreciation by tracking the performance of its underlying index.
- Provides a diversified basket of Israeli innovation stocks, reducing single-stock risk for investors.
- Offers a transparent, rules-based investment approach by replicating a defined index.
What Industry Does IZRL Operate In?
The ARK Israel Innovative Technology ETF (IZRL) operates within the Asset Management - Global industry, specifically targeting the thematic ETF segment. This segment has seen significant growth as investors increasingly seek specialized exposure to high-growth trends and specific geographic markets. IZRL positions itself by focusing exclusively on Israeli companies engaged in transformative innovation, differentiating it from broader technology or international equity ETFs. The competitive landscape includes other country-specific or thematic technology ETFs, but IZRL's unique index methodology and ARK's brand in innovation-focused investing provide a distinct niche. The global asset management industry is characterized by increasing demand for transparent, liquid, and cost-effective investment solutions like ETFs, particularly those offering access to unique growth stories in emerging innovation hubs such as Israel. IZRL taps into the global trend of seeking alpha through specialized, actively managed (or index-tracking with an active philosophy) portfolios.
Who Are IZRL's Key Customers?
- Institutional investors seeking specialized exposure to Israeli technology.
- Retail investors looking for thematic growth opportunities in innovation.
- Financial advisors and wealth managers constructing diversified client portfolios.
- Investors interested in gaining exposure to the 'Startup Nation' economy.
How ARK Israel Innovative Technology ETF Is Valued
Relative to its peer group, IZRL's quantitative score of 47/100 is below the peer average of 70/100.
IZRL Financials
Bull Case vs Bear Case
Bull Case
- Targeted exposure to Israel's highly innovative technology sector, known for its entrepreneurial ecosystem.
- Diversification across multiple high-growth sectors within Israel, including genomics, healthcare, and IT.
- Rules-based index replication strategy offers transparency and consistency.
- Managed by ARK Invest, a firm recognized for its expertise in disruptive innovation.
Bear Case
- Concentrated geographic focus makes the fund vulnerable to regional economic or political instability.
- Relatively small market capitalization ($0.15B) may limit liquidity compared to larger ETFs.
- No dividend yield, which may not appeal to income-focused investors.
- Performance is directly tied to the ARK Israeli Innovation Index, with no active management overlay to mitigate index-specific risks.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
IZRL Latest News
No recent news available for IZRL.
IZRL Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IZRL.
Price Targets
Wall Street price target analysis for IZRL.
IZRL MoonshotScore
What does this score mean?
The MoonshotScore rates IZRL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
ARK Israel Innovative Technology ETF Financial Services Stock: Key Questions Answered
What does ARK Israel Innovative Technology ETF do?
The ARK Israel Innovative Technology ETF (IZRL) is an exchange-traded fund that aims to replicate the performance of the ARK Israeli Innovation Index. Its primary function is to provide investors with focused exposure to publicly traded Israeli companies that are actively engaged in transformative innovation. This includes firms operating across a diverse range of high-growth sectors such as genomics, healthcare, biotechnology, industrial production, manufacturing, the Internet, and information technology. By investing in IZRL, individuals and institutions can access a diversified basket of companies deemed to be at the forefront of technological advancement within Israel, a nation renowned for its entrepreneurial ecosystem and significant contributions to global innovation.
How does ARK Israel Innovative Technology ETF generate returns for investors?
As an exchange-traded fund in the financial services sector, ARK Israel Innovative Technology ETF (IZRL) primarily generates returns for investors through capital appreciation. The fund's objective is to replicate the performance of the ARK Israeli Innovation Index, meaning its value will fluctuate in tandem with the collective stock prices of the innovative Israeli companies held within the index. When these underlying companies experience growth, develop successful new technologies, or expand their market share, their stock prices tend to rise, which in turn increases the net asset value (NAV) of IZRL. Investors then realize returns by selling their shares at a higher price than their purchase price. Unlike some equity ETFs, IZRL does not currently pay a dividend, indicating its focus on growth-oriented companies that typically reinvest earnings back into their operations for further expansion.
What is the investment strategy of the ARK Israel Innovative Technology ETF?
The investment strategy of the ARK Israel Innovative Technology ETF (IZRL) is to passively track the performance of the ARK Israeli Innovation Index. This index is specifically designed to identify and monitor publicly traded Israeli companies whose primary business activities are centered on driving transformative innovation. The fund's managers ensure that IZRL's portfolio composition closely mirrors that of its benchmark index, investing in companies across key high-growth sectors such as genomics, healthcare, biotechnology, industrial production, manufacturing, the Internet, and information technology. This strategy provides investors with a rules-based, transparent, and diversified exposure to the Israeli innovation ecosystem, without engaging in active stock selection or market timing, aiming to capture the overall growth trajectory of this specialized segment.
What are the primary risks associated with investing in IZRL?
Investing in IZRL carries several key risks, primarily stemming from its concentrated geographic and thematic focus. A significant ongoing risk is the geopolitical instability in the Middle East region, which can lead to sudden and severe impacts on the Israeli economy and financial markets, directly affecting the fund's underlying holdings. Economic downturns within Israel also pose a risk, as the fund is exclusively exposed to companies operating in that country. Furthermore, as an ETF focused on innovative technology, it is susceptible to sector-specific volatility and the inherent risks associated with growth companies, which may be more sensitive to market sentiment and economic cycles. The fund's performance is also tied to the ARK Israeli Innovation Index, meaning underperformance of this specific index would directly translate to lower returns for IZRL investors.
What are the key factors to evaluate for IZRL?
ARK Israel Innovative Technology ETF (IZRL) holds an AI score of 47/100 (low). Not financial advice.
How frequently does IZRL data refresh on this page?
IZRL prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven IZRL's recent stock price performance?
ARK Israel Innovative Technology ETF (IZRL) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Targeted exposure to Israel's highly innovative technology sector, known for its entrepreneurial ecosystem. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IZRL overvalued or undervalued right now?
Valuing ARK Israel Innovative Technology ETF (IZRL) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived strictly from the provided source data. No external information or speculation was used.
- The 'competitors' field is an empty array because no FMP PEER TICKERS were provided in the source data, as per instructions.
- The 'ceoProfile' object is null as no CEO data was provided.
- The 'adrAnalysis' and 'otcAnalysis' objects are omitted as the company is a US-listed ETF, not an ADR or OTC stock.